申请人:ORCHID CHEMICALS AND PHARMACEUTICALS LIMITED
公开号:US20040015020A1
公开(公告)日:2004-01-22
A method of converting (Z)-1-(3,5-disubstituted phenyl)-2-(4-substituted phenyl)ethene of general formula (II) to (E)-1-(3,5-disubstituted phenyl)-2-(4-substituted phenyl)ethene of general formula (I)
1
wherein R
1
, R
2
and R
3
are same or different and independently represent (C
1
-C
4
)alkyl, (C
1
-C
4
)alkoxy(C
1
-C
4
)alkyl, (C
1
-C
4
)alkoxy(C
1
-C
4
)alkoxy(C
1
-C
4
)alkyl, allyl, vinyl, silyl, formyl, acyl, aryl(C
1
-C
4
)alkyl or substituted aryl(C
1
-C
4
)alkyl group.
The present invention also provides a process for the conversion of (E)-1-(3,5-disubstituted phenyl)-2-(4-substituted phenyl)ethene of general formula (I) prepared by a process described above to E-resveratrol of the formula (III).
2
一种将通式(II)中的(Z)-1-(3,5-二取代苯基)-2-(4-取代苯基)乙烯转化为通式(I)中的(E)-1-(3,5-二取代苯基)-2-(4-取代苯基)乙烯的方法,其中R1、R2和R3相同或不同,且独立地代表(C1-C4)烷基,(C1-C4)烷氧基(C1-C4)烷基,(C1-C4)烷氧基(C1-C4)烷氧基(C1-C4)烷基,烯丙基,乙烯基,硅基,甲酰基,酰基,芳基(C1-C4)烷基或取代芳基(C1-C4)烷基基团。本发明还提供了一种将通过上述方法制备的通式(I)中的(E)-1-(3,5-二取代苯基)-2-(4-取代苯基)乙烯转化为通式(III)中的E-白藜芦醇的方法。